SEC Form 4 · accession 0001209191-15-053235
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas G Auchincloss
Director
Period of report
Jun 11, 2015
Accepted (ET)
Jun 15, 2015 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonstatutory Stock Option (right to buy)F1 | $16.42 | Jun 11, 2015 | A | 10,000 | A | — | Jun 10, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The shares underlying this option vest in equal quarterly installments over a one-year period, through and including June 11, 2016.